Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients

Inflammatory Bowel Diseases

Volumn 20, Issue 8, 2014, Pages 1329-1340

  Srinath, Arvind I ^a   Goyal, Alka ^a   Zimmerman, Lori A ^b   Newara, Melissa C ^c   Kirshner, Margaret A ^c   McCarthy, Francis Nicole ^c   Keljo, David ^a   Binion, David ^c   Bousvaros, Athos ^b   DeMaso, David R ^b   Youk, Ada ^d   Szigethy, Eva M ^a,b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Abdominal pain; Depression; Inflammatory bowel disease; Psychological

Indexed keywords

ALBUMIN;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADOLESCENT; ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CHILD PSYCHIATRY; CHILDHOOD DISEASE; CROHN DISEASE; CROSS-SECTIONAL STUDY; DEPRESSION; DIARRHEA; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FUNCTION DISORDER; MAJOR CLINICAL STUDY; MALE; NOCTURNAL STOOL; PAIN ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; WEIGHT REDUCTION; ANXIETY; COMPLICATION; FOLLOW UP; PROGNOSIS; PSYCHOLOGY; QUESTIONNAIRE; ULCERATIVE COLITIS;

ABDOMINAL PAIN; ADOLESCENT; ANXIETY; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; SURVEYS AND QUESTIONNAIRES; WEIGHT LOSS;

EID: 84905438691     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000104     Document Type: Article

References (68)

1. Aghazadeh R, Zali MR, Bahari A, et al. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol. 2005;20:1691-1695.
2. Wagtmans MJ, Verspaget HW, Lamers CB, et al. Crohn's disease in the elderly: a comparison with young adults. J Clin Gastroenterol. 1998;27:129-133.
3. Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:778-788.
4. Farrokhyar F, Marshall JK, Easterbrook B, et al. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2006;12:38-46.
5. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004;49:469-474.
6. Srinath AI, Walter C, Newara MC, et al. Pain management in patients with inflammatory bowel disease: insights for the clinician. Therap Adv Gastroenterol. 2012;5:339-357.
7. Zimmerman LA, Srinath AI, Goyal A, et al. The overlap of functional abdominal pain in pediatric Crohn's disease. Inflamm Bowel Dis. 2013;19:826-831.
8. Greenley RN, Kunz JH, Schurman JV, et al. Abdominal pain and health related quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol. 2013;38:63-71.
9. Drossman DA, Leserman J, Li ZM, et al. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med. 1991;53:701-712.
10. Drossman DA, Leserman J, Mitchell CM, et al. Health status and health care use in persons with inflammatory bowel disease. A national sample. Dig Dis Sci. 1991;36:1746-1755.
11. Levenstein S, Li Z, Almer S, et al. Cross-cultural variation in diseaserelated concerns among patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:1822-1830.
12. Long MD, Barnes EL, Herfarth HH, et al. Narcotic use for inflammatory bowel disease and risk factors during hospitalization. Inflamm Bowel Dis. 2012;18:869-876.
13. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1474-1482.
14. Faure C, Giguere L. Functional gastrointestinal disorders and visceral hypersensitivity in children and adolescents suffering from Crohn's disease. Inflamm Bowel Dis. 2008;14:1569-1574.
15. Jonefjäll B, Strid H, Ohman L, et al. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission. Neurogastroenterol Motil. 2013;25:756-e578.
16. Szigethy E, Kenney E, Carpenter J, et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007;46:1290-1298.
17. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009;15:1105-1118.
18. Moser G. Depression and anxiety in inflammatory bowel disease [Article in Spanish]. Gastroenterol Hepatol. 2009;32(suppl 2):9-12.
19. Loftus EV Jr, Guerin A, Yu AP, et al. Increased risks of developing anxiety and depression in young patients with Crohn's disease. Am J Gastroenterol. 2011;106:1670-1677.
20. Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103:1989-1997.
21. Burke P, Meyer V, Kocoshis S, et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry. 1989;28:948-951.
22. Burke P, Kocoshis SA, Chandra R, et al. Determinants of depression in recent onset pediatric inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 1990;29:608-610.
23. Greenley RN, Hommel KA, Nebel J, et al. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol. 2010;35:857-869.
24. Persoons P, Vermeire S, Demyttenaere K, et al. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther. 2005;22:101-110.
25. Drossman DA. Abuse, trauma, and GI illness: is there a link? Am J Gastroenterol. 2011;106:14-25.
26. Elsenbruch S, Rosenberger C, Enck P, et al. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut. 2010;59:489-495.
27. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis. 2006;12:697-707.
28. Saps M, Adams P, Bonilla S, et al. Parental report of abdominal pain and abdominal pain-related functional gastrointestinal disorders from a community survey. J Pediatr Gastroenterol Nutr. 2012;55:707-710.
29. American Psychiatric Association APATFoD-I. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
30. Saps M, Youssef N, Miranda A, et al. Multicenter, randomized, placebocontrolled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009;137:1261-1269.
31. Kovacs M. Children's Depression Inventory (CDI). New York, NY: Multi-Health Systens; 1992.
32. Kaufman J, Birmaher B, Brent DA, et al. K-SADS-PL. J Am Acad Child Adolesc Psychiatry. 2000;39:1208.
33. Walker LS, Greene JW. Children with recurrent abdominal pain and their parents: more somatic complaints, anxiety, and depression than other patient families? J Pediatr Psychol. 1989;14:231-243.
34. Helgeland H, Van Roy B, Sandvik L, et al. Paediatric functional abdominal pain: significance of child and maternal health. A prospective study. Acta Paediatr. 2011;100:1461-1467.
35. Thomsen AH, Compas BE, Colletti RB, et al. Parent reports of coping and stress responses in children with recurrent abdominal pain. J Pediatr Psychol. 2002;27:215-226.
36. Poznanski EOMH. Childrens Depression Rating Scale-revised (CDRS-R). Los Angeles, CA: Western Psychological Services; 1999.
37. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54:1031-1037.
38. Emslie GJ, Ventura D, Korotzer A, et al. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009;48:721-729.
39. Birmaher B, Brent DA, Chiappetta L, et al. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 1999;38:1230-1236.
40. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
41. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423-432.
42. Dellon ES, Ringel Y. Treatment of functional diarrhea. Curr Treat Options Gastroenterol. 2006;9:331-342.
43. Keohane J, O'Mahony C, O'Mahony L, et al. Irritable bowel syndrometype symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol. 2010;105:1788, 1789-1794, quiz 1795.
44. Piche T, Ducrotte P, Sabate JM, et al. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:626-e174.
45. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389-396.
46. Graff LA, Clara I, Walker JR, et al. Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors. Clin Gastroenterol Hepatol. 2013;11:1140-1146.
47. Privitera GJ, Misenheimer ML, Doraiswamy PM. From weight loss to weight gain: appetite changes in major depressive disorder as a mirror into brain-environment interactions. Front Psychol. 2013;4:873.
48. Steinhoff MM, Kodner IJ, DeSchryver-Kecskemeti K. Axonal degeneration/necrosis: a possible ultrastructural marker for Crohn's disease. Mod Pathol. 1988;1:182-187.
49. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
50. Sandborn WJ. How to avoid treating irritable bowel syndrome with biologic therapy for inflammatory bowel disease. Dig Dis. 2009;27(suppl 1):80-84.
51. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004;127:723-729.
52. Siddiki H, Ramos-Rivers C, Regueiro M, et al. Radiographic characterization of small bowel segments proximal to the ileocolonic anastomosis in Crohn's disease (CD): correlation of anastomotic type with bowel diameter and quality of life. Am J Gastroenterol. 2013;108:S536-S537.
53. Katon W. The impact of major depression on chronic medical illness. Gen Hosp Psychiatry. 1996;18:215-219.
54. Loonen HJ, Derkx BH, Griffiths AM. Pediatricians overestimate importance of physical symptoms upon children's health concerns. Med Care. 2002;40:996-1001.
55. Jones NP, Siegle GJ, Proud L, et al. Impact of inflammatory bowel disease and high-dose steroid exposure on pupillary responses to negative information in pediatric depression. Psychosom Med. 2011;73:151-157.
56. Walker EA, Gelfand MD, Gelfand AN, et al. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry. 1996;18:220-229.
57. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterol. 2007;7:38.
58. Gupta N, Bostrom AG, Kirschner BS, et al. Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients. Inflamm Bowel Dis. 2010;16:638-644.
59. Verma-Gandhu M, Verdu EF, Bercik P, et al. Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut. 2007;56:358-364.
60. Bryant RV, van Langenberg DR, Holtmann GJ, et al. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status. J Gastroenterol Hepatol. 2011;26:916-923.
61. Saps M, Seshadri R, Sztainberg M, et al. A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr. 2009;154:322-326.
62. Meesters C, Muris P, Ghys A, et al. The children's somatization inventory: further evidence for its reliability and validity in a pediatric and a community sample of Dutch children and adolescents. J Pediatr Psychol. 2003;28:413-422.
63. Malaty HM, Abudayyeh S, O'Malley KJ, et al. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings. Pediatrics. 2005;115:e210-e215.
64. Weinland SR, Morris CB, Hu Y, et al. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment. Am J Gastroenterol. 2011;106:1813-1820.
65. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004;66:79-84.
66. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101-2107.
67. Ghia JE, Blennerhassett P, Deng Y, et al. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology. 2009;136:2280-2288, e2281-2284.
68. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54:1481-1491.